Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
2.170
-0.120 (-5.24%)
Jul 29, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Abuse and Overdose Resistant Pain Technology
5.21M
Log In
Log In
Log In
Abuse and Overdose Resistant Pain Technology Growth
133.58%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
United States
5.21M
Log In
Log In
Log In
United States Growth
133.58%
Log In
Log In
Log In